Related Experiment Videos
Experience with insulin analogues in children.
Thomas Danne1, Dorothee Deiss, Werner Hopfenmüller
1Diabetes-Zentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, Germany. danne@hka.de
Hormone Research
|April 30, 2002
Summary
Rapid-acting and long-acting insulin analogues show potential benefits for children with diabetes, but long-term effects on glycemic control require further study. Continuous glucose monitoring aids in tailoring insulin analogue treatments for optimal results.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Limited data exists on rapid- and long-acting insulin analogues in pediatric populations.
- Hypoglycemia reduction is noted with insulin analogues, but long-term glycemic control remains debated.
- Continuous glucose monitoring (CGM) presents a novel approach for personalized insulin analogue therapy.
Purpose of the Study:
- To evaluate the efficacy and safety of insulin analogues in pediatric patients with diabetes.
- To assess the role of continuous glucose monitoring in optimizing insulin analogue treatment regimens.
- To compare postprandial rapid-acting insulin analogue administration with preprandial regular insulin.
Main Methods:
- A study involving 29 adolescents with diabetes.
- Utilized continuous glucose monitoring systems to tailor insulin analogue therapy.
- Compared postprandial rapid-acting analogue administration against preprandial regular insulin.
Main Results:
- Confirmed non-inferiority of postprandial rapid-acting analogue versus preprandial regular insulin.
- Observed significant mealtime variations, indicating increased analogue needs at breakfast and dinner.
- Highlighted the potential benefits of insulin analogues in addressing common pediatric diabetes challenges.
Conclusions:
- Insulin analogues may offer advantages in pediatric diabetes management.
- Continuous glucose monitoring facilitates personalized treatment adjustments.
- Long-term clinical observation is crucial to determine the individual value of insulin analogues in children.